Human Molecular Genetics, 2000, Vol. 9, No. 4 477-488
© 2000 Oxford University Press
Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoA
Departments of 1Molecular and Human Genetics, 2Cell Biology and 3Pathology and 4Howard Hughes Medical Institute, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA and 5Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada
Microphthalmia with linear skin defects (MLS) is an X-linked dominant, male-lethal syndrome characterized by microphthalmia, aplastic skin and agenesis of the corpus callosum, and is caused by the deletion of a 500 kb critical region in Xp22.3. Our laboratory isolated a novel rho GTPase-activating protein (rhoGAP) gene named ARHGAP6 from the MLS region. ARHGAP6 contains 14 exons encoding a 974 amino acid protein with three putative SH3-binding domains. Because exons 214 are deleted in all MLS patients, we hypothesized that ARHGAP6 may be responsible for some of the phenotypic features of MLS. We pursued two approaches to study the function of ARHGAP6 and its role in the pathogenesis of MLS: gene targeting of the rhoGAP domain in mouse embryonic stem cells and in vitro expression studies. Surprisingly, loss of the rhoGAP function of Arhgap6 does not cause any detectable phenotypic or behavioral abnormalities in the mutant mice. Transfected mammalian cells expressing ARHGAP6 lose their actin stress fibers, retract from the growth surface and extend thin, branching processes resembling filopodia. The ARHGAP6 protein co-localizes with actin filaments through an N-terminal domain and recruits F-actin into the growing processes. Mutation of a conserved arginine residue in the rhoGAP domain prevents the loss of stress fibers but has little effect on process outgrowth. These results suggest that ARHGAP6 has two independent functions: one as a GAP with specificity for RhoA and the other as a cytoskeletal protein that promotes actin remodeling.
+ To whom correspondence should be addressed. Tel: +1 713 798 6558; Fax: +1 713 798 8728; Email: hzoghbi@bcm.tmc.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Almog, S. Lazar, N. Reiss, N. Etkovitz, E. Milch, N. Rahamim, M. Dobkin-Bekman, R. Rotem, M. Kalina, J. Ramon, et al. Identification of Extracellular Signal-regulated Kinase 1/2 and p38 MAPK as Regulators of Human Sperm Motility and Acrosome Reaction and as Predictors of Poor Spermatozoan Quality J. Biol. Chem., May 23, 2008; 283(21): 14479 - 14489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Zimmerman, W. Rizzo, K. R. Shockley, D. M. Raizen, N. Naidoo, M. Mackiewicz, G. A. Churchill, and A. I. Pack Multiple mechanisms limit the duration of wakefulness in Drosophila brain Physiol Genomics, November 21, 2006; 27(3): 337 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Lugtenberg, A P M de Brouwer, T Kleefstra, A R Oudakker, S G M Frints, C T R M Schrander-Stumpel, J P Fryns, L R Jensen, J Chelly, C Moraine, et al. Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH J. Med. Genet., April 1, 2006; 43(4): 362 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lavelin and B. Geiger Characterization of a Novel GTPase-activating Protein Associated with Focal Adhesions and the Actin Cytoskeleton J. Biol. Chem., February 25, 2005; 280(8): 7178 - 7185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bailey, A. J Tyson-Capper, K. Gilmore, S. C Robson, and G N. Europe-Finner Identification of human myometrial target genes of the cAMP pathway: the role of cAMP-response element binding (CREB) and modulator (CREM{alpha} and CREM{tau}2{alpha}) proteins J. Mol. Endocrinol., February 1, 2005; 34(1): 1 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Prakash, T. A. Cormier, A. E. McCall, J. J. Garcia, R. Sierra, B. Haupt, H. Y. Zoghbi, and I. B. Van den Veyver Loss of holocytochrome c-type synthetase causes the male lethality of X-linked dominant micro-phthalmia with linear skin defects (MLS) syndrome Hum. Mol. Genet., December 1, 2002; 11(25): 3237 - 3248. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kayserili, T. C Cox, L. L Cox, S. Basaran, G. Kiliç, A. Ballabio, and M. Yüksel-Apak Molecular characterisation of a new case of microphthalmia with linear skin defects (MLS) J. Med. Genet., June 1, 2001; 38(6): 411 - 417. [Full Text] |
||||




